عبوة من 10 قوارير6 متوفروفّر 22٪CJC-1295 + Ipamorelin 5 mg + 5 mg
تركيبة كلاسيكية GHRH + محاكي غريلين
CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.
للاستخدام البحثي فقط. يُباع هذا المركب حصراً لأبحاث in-vitro والأغراض المختبرية، وهو غير مخصص للاستهلاك البشري أو للاستخدام العلاجي. بالشراء تؤكد أنك باحث مؤهَّل وتوافق على إخلاء المسؤولية الكامل.
لم يتبقَّ سوى 6 عبوات
قارورة بحثية مزدوجة تجمع نظير GHRH CJC-1295 مع محاكي الغريلين الانتقائي Ipamorelin. أكثر تركيبات مفرزات GH ثنائية الآلية دراسةً في أبحاث الببتيدات.
CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.
Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.
الآلية
يدعم CJC-1295 الإشارة القاعدية لمستقبل GHRH بينما يدفع Ipamorelin نبضات انتقائية لمستقبل الغريلين. تشير الأبحاث إلى أنماط تآزرية وفسيولوجية لإطلاق GH لدى أفراد الدراسة.
تم التحقق بتقنية HPLC وفق مواصفة نقاء ≥99%. اختُبر بشكل مستقل لدى مختبرات طرف ثالث معتمدة.
CJC-1295: DAC vs no-DAC
CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.
CJC-1295 + Ipamorelin — الأسئلة الشائعة
What is the CJC-1295 + Ipamorelin stack?
It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.
How does CJC-1295 differ from Ipamorelin?
CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.
Is CJC-1295 + Ipamorelin legal in Australia?
Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.
What does selective mean for Ipamorelin?
Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.
What is the typical CJC-1295 + Ipamorelin research dosage?
Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Are CJC-1295 and Ipamorelin used together?
Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.
أدلة مرتبطة بـ CJC-1295 + Ipamorelin
يستكشف الباحثون أيضاً
مميّزعبوة من 10 قواريروفّر 17٪HGH
مسحوق مجفَّف بالتجميد10 IU · 4 strengths
هرمون نمو بشري معاد التركيب
ضمن 2 تركيبات
عبوة من 10 قواريروفّر 18٪Tesamorelin
مسحوق مجفَّف بالتجميد10 mg · 3 strengths
نظير GHRH مثبت
ضمن تركيبة 1
مميّزعبوة من 10 قواريروفّر 22٪Melanotan II
مسحوق مجفَّف بالتجميد10 mg
ببتيد بحثي نظير α-MSH